Strategies for glycemic control in nonobese and obese type 2 diabetic patients with coronary artery disease.

Affiliation

Department of Diabetes, Endocrinology, and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: [Email]

Abstract

This study aimed to assess strategies of insulin-providing (IP) or insulin-sensitizing (IS) therapy for glycemic control in nonobese diabetic patients with coronary artery disease (CAD) with possibly higher cardiovascular risk and lower insulin secretion than obese diabetic patients with CAD.

Keywords

Cardiovascular events,Coronary artery disease,Insulin-providing therapy,Insulin-sensitizing therapy,Nonobese,Type 2 diabetes,

OUR Recent Articles